NO20083869L - Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte - Google Patents

Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte

Info

Publication number
NO20083869L
NO20083869L NO20083869A NO20083869A NO20083869L NO 20083869 L NO20083869 L NO 20083869L NO 20083869 A NO20083869 A NO 20083869A NO 20083869 A NO20083869 A NO 20083869A NO 20083869 L NO20083869 L NO 20083869L
Authority
NO
Norway
Prior art keywords
pain
beta
treatment
alkyl
inflammatory disorders
Prior art date
Application number
NO20083869A
Other languages
English (en)
Norwegian (no)
Inventor
Andrew Douglas Baxter
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of NO20083869L publication Critical patent/NO20083869L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4458—Non condensed piperidines, e.g. piperocaine only substituted in position 2, e.g. methylphenidate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20083869A 2006-03-09 2008-09-09 Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte NO20083869L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0604826.8A GB0604826D0 (en) 2006-03-09 2006-03-09 The treatment of inflammatory disorders and pain
PCT/GB2007/000821 WO2007102011A1 (en) 2006-03-09 2007-03-09 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain

Publications (1)

Publication Number Publication Date
NO20083869L true NO20083869L (no) 2008-10-07

Family

ID=36241342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083869A NO20083869L (no) 2006-03-09 2008-09-09 Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte

Country Status (12)

Country Link
US (1) US20100016357A1 (zh)
EP (1) EP1993544A1 (zh)
KR (1) KR20090021141A (zh)
CN (1) CN101426501A (zh)
AU (1) AU2007222209A1 (zh)
BR (1) BRPI0708624A2 (zh)
CA (1) CA2646883A1 (zh)
GB (1) GB0604826D0 (zh)
IL (1) IL193943A0 (zh)
MX (1) MX2008011508A (zh)
NO (1) NO20083869L (zh)
WO (1) WO2007102011A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201714740D0 (en) * 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756973A (fr) * 1969-10-08 1971-04-02 Smith Kline French Lab Hydroxyphenyl-2-piperidinylcarbinols et compositions pharmaceutiques encontenant
US3985887A (en) * 1973-10-19 1976-10-12 Smithkline Corporation 3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols as β-adrenergic stimulants
EP1496917B1 (en) * 2002-04-19 2005-12-07 Astion Development A/S Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
WO2004091540A2 (en) * 2003-04-15 2004-10-28 Theraquest Biosciences, Llc Methods of treating pain and compositions for use therefor
WO2005102296A2 (en) * 2004-04-23 2005-11-03 Heptagen Limited Combinations for the treatment of immunoproliferative skin disorders such as psoriasis
BRPI0514931A (pt) * 2004-09-07 2008-07-01 Sosei R & D Ltd tratamento de desordens inflamatórias e dor
CA2604758C (en) * 2005-04-13 2014-11-25 Astion Pharma A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin

Also Published As

Publication number Publication date
IL193943A0 (en) 2009-08-03
KR20090021141A (ko) 2009-02-27
EP1993544A1 (en) 2008-11-26
CN101426501A (zh) 2009-05-06
GB0604826D0 (en) 2006-04-19
MX2008011508A (es) 2008-10-23
WO2007102011A1 (en) 2007-09-13
AU2007222209A1 (en) 2007-09-13
CA2646883A1 (en) 2007-09-13
BRPI0708624A2 (pt) 2011-06-07
US20100016357A1 (en) 2010-01-21

Similar Documents

Publication Publication Date Title
NO20071534L (no) Behandling av inflammatoriske forstyrrelser og smerte
ATE517896T1 (de) P38-kinase-inhibitoren
NZ591712A (en) Imidazopyridazinecarbonitriles useful as kinase inhibitors
NZ593030A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
NO20081349L (no) Pyrrolopyrimidinderivater som Syk-inhibitorer
DK1109813T3 (da) Pyrroloindoler, pyridoindoler og azepinoindoler som 5-HT2C-agonister
NO20075623L (no) Benzodioksan- og benzodioksolanderivater og deres anvendelse
NO20075626L (no) Heteroarylbenzamid-derivater for anvendelse som GLK-aktivatorer i behandling av diabetes
GT200600105A (es) Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos.
TW200626601A (en) Novel compounds
EA201000562A1 (ru) Производные n-(пиразол-3-ил)бензамида в качестве активаторов глюкокиназы
UY30323A1 (es) Uso de bifenilamidas de acido arilcarboxilico para el tratamiento de semillas
GB0402143D0 (en) Novel compounds
IL189194A (en) Benzimidazoles are conserved as kinase inhibitors and their use in the preparation of cancer drugs
NO20083869L (no) Bruk av beta-aminoalkoholer for behandling av betennelseslidelser og smerte
JP2016520515A5 (zh)
SE0301232D0 (sv) Novel use
EA201001367A1 (ru) Производные карбоксамид-гетероарила для лечения диабета
MX2011011764A (es) Compuestos de carboxamida y su uso como inhibidores de calpaina.
NO20071574L (no) Arylsulfonylstilbenderivater for behandling av insomni og beslektede tilstander.
NZ627631A (en) Benzoheterocyclic compounds and use thereof
EA200602180A1 (ru) Производные 2-(1h-индолилсульфанил)ариламина для применения при лечении аффективных расстройств, боли, нгдв и стрессового недержания мочи
DK1949893T3 (da) Quinazolinderivater, der kan anvendes til behandling af perifer arteriel sygdom og som phosphodiesteraseinhibitorer
GB0402138D0 (en) Novel compounds
PE20070169A1 (es) Derivados del 4,5-diarilpirrol como antagonistas de receptores cb1

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application